Dominik Maurer

This inventor holds 38 USPTO granted patents and 33 published patent applications and 14 EPO patents, primarily in T Cell Receptors. Top assignees: Immatics Biotechnologies Gmbh, Emmatics Biotechmiogieg Gmbh, Immatics US, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominik Maurer. Retrieved from https://idiyas.com/inventor/dominik-maurer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 33)

% Patents Active = 84.2

EPO Patents = 14 (Patent Applications = 27)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 79(Granted Patents)

Location History:

Reutlingen, DE (2020)
Mössingen, DE (2020)
Moessingen, DE (2020 - 2024)
Tuebingen, DE (2024)

Company Filing History:

37 out of 728

Immatics Biotechnologies Gmbh

patents

1 out of 1

Emmatics Biotechmiogieg Gmbh

where one patent can have more than one assignee

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

T Cell Receptors

Immunotherapy

Antigen Binding Proteins

Peptide-MHC Affinity

Cancer Treatment

Transfected T-Cells

Dual Specificity Polypeptide

High Throughput Screening

Engineered T Cells

PRAME Binding

MAGE-A Binding

CT45 Binding

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570760 - Antigen binding proteins specifically binding PRAME (2026-03-10),

2. 12297252 - T cell receptors with improved pairing (2025-05-13),

3. 12269881 - Antigen binding proteins specifically binding MAGE-A (2025-04-08),

4. 12209137 - Antigen binding proteins specifically binding CT45 (2025-01-28),

5. 12188932 - Method for high throughput peptide-MHC affinity screening for TCR ligands (2025-01-07),

6. 12011459 - Methods for manufacturing T cells by direct sorting and compositions thereof (2024-06-18),

7. 11998607 - T cell receptors and immune therapy using the same (2024-06-04),

8. 11945854 - Transfected T-cells and T-cell receptors for use in immunotherapy against cancers (2024-04-02),

9. 11939376 - T cell receptors and immune therapy using the same (2024-03-26),

10. 11932689 - Engineered T cell receptors and immune therapy using the same (2024-03-19),

11. 11905328 - Dual specificity polypeptide molecule (2024-02-20),

12. 11859009 - Antigen binding proteins specifically binding PRAME (2024-01-02),

13. 11840577 - Antigen binding proteins specifically binding MAGE-A (2023-12-12),

14. 11730796 - Transfected t-cells and t-cell receptors for use in immunotherapy against cancers (2023-08-22),

15. 11236145 - T cell receptors and immune therapy using the same against PRAME positive cancers (2022-02-01),

Title: Inventor Dominik Maurer: Revolutionizing Technology in Moessingen

Introduction: Dominik Maurer is a visionary inventor based in Moessingen, Germany, known for his groundbreaking contributions to the field of technology.

Latest Patents: Dominik Maurer holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Dominik Maurer has worked with leading tech companies to develop innovative solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Dominik Maurer has collaborated with top researchers, engineers, and scientists to push the boundaries of technological advancements and bring cutting-edge products to the market.

Conclusion: Dominik Maurer's relentless pursuit of innovation and his passion for creating a sustainable future through technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.